AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report) major shareholder Richard Cashin, Jr. acquired 447,100 shares of the business's stock in a transaction that occurred on Friday, March 20th. The stock was bought at an average cost of $9.91 per share, for a total transaction of $4,430,761.00. Following the completion of the purchase, the insider directly owned 16,312,698 shares in the company, valued at $161,658,837.18. This represents a 2.82% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
AdaptHealth Stock Up 4.6%
AHCO opened at $10.37 on Tuesday. The firm has a market cap of $1.41 billion, a P/E ratio of -18.85, a price-to-earnings-growth ratio of 1.14 and a beta of 1.76. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.81 and a current ratio of 1.02. The business has a 50 day moving average price of $10.09 and a 200 day moving average price of $9.72. AdaptHealth Corp. has a twelve month low of $7.11 and a twelve month high of $11.17.
AdaptHealth (NASDAQ:AHCO - Get Free Report) last announced its quarterly earnings results on Tuesday, February 24th. The company reported ($0.76) EPS for the quarter, missing the consensus estimate of $0.34 by ($1.10). AdaptHealth had a negative net margin of 2.18% and a positive return on equity of 3.42%. The company had revenue of $846.29 million for the quarter, compared to analyst estimates of $832.51 million. During the same quarter last year, the business earned $0.34 EPS. The company's revenue for the quarter was down 1.2% on a year-over-year basis. Research analysts forecast that AdaptHealth Corp. will post 0.88 EPS for the current year.
Analyst Ratings Changes
Several research analysts recently commented on the stock. Zacks Research upgraded shares of AdaptHealth from a "strong sell" rating to a "hold" rating in a report on Thursday, January 1st. Royal Bank Of Canada restated an "outperform" rating and set a $13.00 price target on shares of AdaptHealth in a report on Wednesday, February 25th. Wall Street Zen downgraded AdaptHealth from a "buy" rating to a "hold" rating in a research report on Saturday, February 28th. Leerink Partners dropped their price objective on AdaptHealth from $13.00 to $12.00 and set an "outperform" rating on the stock in a research note on Thursday, February 26th. Finally, Weiss Ratings cut AdaptHealth from a "hold (c-)" rating to a "sell (d)" rating in a research report on Wednesday, February 25th. Four analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $13.25.
View Our Latest Research Report on AHCO
Hedge Funds Weigh In On AdaptHealth
A number of institutional investors and hedge funds have recently bought and sold shares of AHCO. Deerfield Management Company L.P. raised its stake in AdaptHealth by 15.9% during the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company's stock valued at $102,726,000 after purchasing an additional 1,572,835 shares during the last quarter. Dimensional Fund Advisors LP grew its position in AdaptHealth by 15.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,982,070 shares of the company's stock worth $53,537,000 after purchasing an additional 809,459 shares during the last quarter. Reinhart Partners LLC. increased its holdings in shares of AdaptHealth by 10.6% during the 4th quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company's stock worth $80,684,000 after purchasing an additional 773,727 shares during the period. Kennedy Capital Management LLC increased its holdings in shares of AdaptHealth by 48.8% during the 3rd quarter. Kennedy Capital Management LLC now owns 2,090,138 shares of the company's stock worth $18,707,000 after purchasing an additional 685,554 shares during the period. Finally, Iron Triangle Partners LP raised its position in shares of AdaptHealth by 35.6% during the fourth quarter. Iron Triangle Partners LP now owns 2,609,003 shares of the company's stock valued at $25,986,000 after buying an additional 684,871 shares during the last quarter. Institutional investors own 82.67% of the company's stock.
About AdaptHealth
(
Get Free Report)
AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.
The company's respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
